Latest Networking News

Janus Electric has secured a repeat A$3.1 million order from California operator King Fio Trucking, lifting its North American order book to 124 trucks. The expansion reuses existing charging and battery-swapping infrastructure, but remains conditional on California incentive approval.

Rhythm Biosciences has widened access to its ColoSTAT blood test, lifted quarterly revenue 64% and advanced reimbursement and NHS evaluation work. The progress sits alongside A$1.803 million in cash and an estimated 1.22 quarters of funding at the current operating burn.

Elementos has secured approval for the 8.1km access corridor at its Oropesa tin project in Spain and made its Robledollano smelter option unconditional. The company ended September with A$38.6 million in cash, but still needs primary permits, financing and offtake agreements before a final investment decision.

Janus Electric has signed a non-binding MOU with ConGlobal for a proposed 20-truck Class 8 conversion pilot in Texas. A successful pilot could open a pathway to conversion, battery-swapping and servicing operations across ConGlobal’s 31 US depots, although no binding orders or commercial terms have been agreed.

Artrya has converted its largest US customer and first SAPPHIRE Study participant into a five-year commercial agreement, while delaying its planned Coronary Flow FDA submission to strengthen clinical evidence. The Salix rollout is gaining traction, but revenue remains early and scan volumes are undisclosed.

Metallium has signed a non-binding MOU with global commodity trader Traxys to explore feedstock, processing, offtake and financing opportunities for U.S. critical metals. The framework could improve the path to commercial scale, but it contains no binding volumes, prices, funding or sales commitments.

Echo IQ’s FDA-cleared EchoSolv AS platform processed 9,697 full-result assessments in the September quarter, while the company ended the period with A$107.8 million in cash. The stronger balance sheet gives it room to pursue US enterprise deployments, but commercial conversion and the unresolved EchoSolv HF regulatory pathway remain the key tests.

Everest Metals’ Mt Edon project has been selected as Australia’s representative site in a five-year German-funded exploration program and accepted into the European Union’s Raw Materials Mechanism. The recognition may improve access to technical expertise, strategic partners and potential financing, although no funding, offtake or development commitment was announced.

Supply Network is targeting around $50 million of additional revenue in FY2027 after delivering 15.5% sales growth and expanding its Multispares network across Australia and New Zealand. The next phase includes a planned $9 million Penrith branch and further capacity upgrades, although the company has not quantified the earnings return from that investment.

Bass Oil’s September-quarter production rose 21% to 23,944 barrels after Bunian 6 came online, while sales revenue reached A$2.82 million. Cash fell to A$2.07 million as drilling and development spending continued, leaving the company with an estimated two quarters of funding under its Appendix 5B calculation.

New research from the NEPTUNE cohort has strengthened the biological rationale for Dimerix’s DMX-200 kidney drug, linking CCR2 activity and urinary MCP-1 levels with poorer outcomes in FSGS. The findings support the drug’s mechanism, but do not yet demonstrate Phase 3 efficacy.

Aussie Broadband has reaffirmed its FY27 underlying EBITDA guidance of $205 million to $215 million after adding more than 193,000 broadband connections since June. The company says major customer migrations are nearing completion, shifting the focus from scale-building to integration and productivity.